Introduction
Gene therapy to ameliorate left ventricular dysfunction offers a potential therapeutic strategy for patients with heart failure. Molecular cardiac surgery with recirculating delivery (MCARDீ) is a novel cardiac-specific delivery platform via the use of cardiopulmonary bypass (CPB). Although viewed as technically complex, we and others have demonstrated effective use of CPB, with minimal procedure-related complications and very efficient cardiac gene delivery w1-4x. Taken together, these studies indicate the potential for an efficient CPB-based cardiac-specific vector-mediated gene delivery platform combined with a promising therapeutic vectorytransgene to be utilized in select patients with cardiac failure.
In this study, we aim to quantitatively assess the cardiac isolation efficiency of the MCARDீ procedure and to elucidate the extent of collateral gene expression in distant organs. We further review the main technical features of the MCARDீ to evaluate the potential for clinical application.
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Materials and methods

Animal use and surgical protocol
All animals received humane care in compliance with the NIH and guidelines established by the University of Pennsylvania. Nine Dorsett male sheep (approx. one-year-old), weighing 38.6"3.4 kg, were the basis for the results presented here.
Details of the surgical technique with complete and incomplete cardiac isolation
After initiating CPB, the right and the left azygous veins are ligated; a temporary snare is place around the middle cardiac vein; vent cannulas are placed into the left ventrical (LV) through the apex and into the right ventrical (RV) through the outflow tract. The LV, RV and aortic root vents are connected via a Y connector to the venous limb of the cardiac venous return circuit. The arterial limb of the cardiac circuit is connected to the coronary sinus catheter. The aorta is cross-clamped and cold crystalloid cardioplegia is delivered antegrade. The heart is isolated by tightening the superior vena cava (SVC) and inferior vena cava (IVC) snares, cross-clamping the pulmonary artery and tightening the snare around the middle cardiac vein (Fig. 1) . With the heart fully decompressed, cardiac circuit flow is initiated until the coronary sinus pressure equals 60-80 mmHg. Flow Downloaded from https://academic.oup.com/icvts/article-abstract/11/6/727/830137 by guest on 28 December 2018 was about 60-100 mymin average. The virus solution is injected into the retrograde catheter and allowed to dwell for 10 minutes and recirculation commences for 20 minutes. The coronary circuit is then flushed antegrade with 1000 ml of hetastarch to washout residual vector. Rewarming is initiated and the animal is weaned from CPB and closed in standard fashion. During incomplete cardiac isolation (ns1), after cross-clamping, the snares on the SVC and IVC were not tightened, resulting in communication between the cardiac and systemic circuits.
Vector design and production
1=10 genome copies (GC) of single-stranded or self-14 complimentary recombinant adeno-associated virus 6 vectors, encoding green fluorescent protein (GFP) under the control of the human cytomegalovirus promoter immediate early enhancerypromoter with a splice donoryacceptor sequence and polyadenylation signal from the human globin gene are produced w5x.
Real-time quantitative polymerase chain reaction (RT QPCR)
RT PCR was performed using the MyiQ RT PCR Detection System (Bio-Rad Corporation, CA, USA) and analyzed using the MyiQ software package (Bio-Rad Corporation, CA, USA). QPCR analysis was performed in optical 96-well plates using iQ SYBRGreen Supermix (Bio-Rad Laboratories, Hercules, CA, USA).
Histological analysis
Hematoxylin and eosin and Masson's trichrome staining were performed on microscopic sections.
Immunostaining analysis
GFP expression was detected in frozen tissue sections by direct fluorescence and by immunostaining. For colorimetric detection of GFP we used polyclonal rabbit anti-GFP antibody as a primary and HRP-conjugated goat anti-rabbit IgG (Invitrogen, CA, USA) as a secondary antibodies according to manufacture's protocol.
Statistical methods
Comparisons between the blood vector GC cardiac and systemic concentrations at specific time points were performed using two-sided paired Student's t-tests. One way analysis of variance (ANOVA) was used to compare blood QPCR in the systemic and cardiac circulation at the different time points.
Results
Genome biodistribution
In these experiments, we chose to illustrate the observed GC on a logarithm (log) scale to facilitate ease of interpretation of the data. With complete cardiac isolation, the blood vector GC concentration trended from 9.59"0.73 to 9.05"0.65 (log GCycm ). No GC were detectable in 3 the systemic circuit during 10 minutes of dwelling and 20 minutes of recirculation (P-0.001). After completion of the recirculation interval and the washing procedure, the initial systemic blood vector GC concentration significantly decreased to 6.68"1.08 log GCycm or more than 800 times 3 less than the starting cardiac circuit concentration (P-0.001) ( Fig. 2a) .
Conversely, during incomplete cardiac isolation, there was a gradual equalization of the vector genome concentrations in both the cardiac and systemic circuits. Postrecirculation washout of the circuit did not lead to any notable change in the systemic biodistribution of vector genomes, suggesting that equilibrium had already been reached (Fig. 2b) .
MCARDீ efficiency
The initial blood concentration of vector in the cardiac circuit is determined by calculating the dilution factor (e.g. 1=10 divided by the real time cardiac circuit volume plus 14 40 ml vial content). The cardiac circuit volume typically was 280"40 ml. Here, we define cardiac isolation efficiency as (maximum cardiac circuit vector concentrationmaximum systemic vector concentration)/(maximum cardiac circuit vector concentration)=100s99.65%. Repeated bio-distribution studies determined insignificant amounts GC (-0.002%) in various circuit components. Although GC distribution graphically appears large secondary to the log Downloaded from https://academic.oup.com/icvts/article-abstract/11/6/727/830137 by guest on 28 December 2018 , kidney (c), and spleen (d) cells are shown after histochemical assay for GFP activity. This assay reveals significant collateral organ gene expression after incomplete cardiac isolation. In contrast, there is minimal if any evidence of collateral organ gene expression after complete cardiac isolation. These photomicrographs were taken from animals killed four weeks after the MCARDீ procedure was performed. scale representation, the absolute amount of GC remaining in the systemic circuit postrecirculation is relatively low when converted to absolute integer values. The systemic circuit volume is estimated at 75 ml per kg of animal weight. Converted to the linear scale, 6.68 (log GCycm ) is 3 4,786,000 GCyml. Therefore, after conversion to an absolute integer value, it is clear that only 0.002% of 1=10 14 GC injected was detectable in the systemic circulation.
Collateral organ gene expression
In the case with incomplete cardiac isolation, immunohistochemical staining revealed significant reporter gene expression in the lungs, liver, kidneys and spleen likely resulting from the relatively high systemic biodistribution of AAV6 vector genomes. In contrast, there was no immunohistochemical evidence of GFP expression evident in collateral organs four weeks after the MCARDீ procedure with complete cardiac isolation. Furthermore, the surrounding tissue of all main organs after MCARDீ showed no evidence of significant inflammation or tissue damage which might have resulted as an untoward consequence of viral transfection ( Fig. 3a-d) .
Operative results
All of the animals in this series survived to euthanasia at four weeks. Average bypass and cross-clamp times were 128.9"11.1 minutes and 67.9"9.6 minutes, respectively. All animals were weaned from CPB with mild inotropic support and were extubated within three to five hours of surgery.
Signs of inflammation and evidence of myocardial edema, necrosis or fibrosis were absent in all histological samples procured, following euthanasia at four weeks.
Discussion
Antegrade vs. retrograde route of gene delivery
In our initial experiments, we used antegrade intracoronary viral gene delivery w6x. Subsequently, we utilized gene transfer using retrograde coronary delivery w2x resulting in more efficient myocardial gene transfer. These results were also confirmed by Boekstegers et al. w7x . Retrograde cardioplegia compared to antegrade provides a more uniform distribution of cardioplegia in the presence of coronary artery disease. Conversely, the quantity of cardioplegia administered retrograde that traverses the capillary beds is significantly lower than for the antegrade delivery method due to shunting through the thebesian and arteriosinusoidal channels into the ventricular chambers (Fig. 4) . Parlington et al. w8x demonstrated that nutritive flow in the LV averaged 65% by retrograde perfusion vs. 87% when given antegrade. Disadvantages of retrograde cardioplegia include relatively poor perfusion of the RV. We and others believe that the coronary venous infusion allows for prolonged adhesion time of the vector to cardiac endothelium and results both in an increase in endothelial permeability as well as a higher pressure gradient across the interstitial capillaries and venules, promoting filtration of macromolecular (nanoparticle-sized) vectors into the interstitium of the heart w1x.
Coronary venous and arterial anatomy
In sheep, the coronary venous system is similar to the human. A prominent left azygous vein enters on the left side of the ovine heart and drains into the coronary sinus. This anatomical feature is the main difference between ovine and human coronary venous anatomy w9x. Therefore, ligation of the left azygous vein is a necessary condition for complete cardiac isolation in the ovine model. The coronary venous system not only connects with myocardial capillaries but also interconnects with other coronary veins by way of veno-venous collaterals and with the ventricular and atrial cavities directly through the thebesian vessels. The anatomy of the thebesian veins in sheep is similar to that of the human heart and is divided into three components. The first part drains blood from the capillary bed into the ventricles; the second part drains blood from arteries into the ventricles without traversing capillary beds; and the third part forms direct connections with the coronary veins, shunting blood from these vessels into the ventricles w10x.
To understand how retrograde perfusion of virus might facilitate global and efficient transduction of cardiac myocytes, the interrelationship of the coronary venous and arterial anatomy must be considered. Arterioles give rise directly to capillaries andyor metarterioles. Just proximal to their origin from arterioles, capillaries have a precapillary sphincter. Blood flow through capillary channels is designed for exchange of nutrients and metabolites, referred to as nutrient flow. In some parts of the microcirculation, blood flow bypasses the capillary bed, moving through a connection called an arterio-venous shunts, which directly connects an arteriole and a venule. This type of blood flow is called non-nutrient flow because it does not allow for nutrient exchange. When there is recirculation of vector genomes in the (retrograde) direction, high venous pressure is directly transferred to the venule and capillary where nutrient flow (filtration) takes place. In the antegrade direction, precapillary sphincters are likely to greatly diminish the electromotive force (pressure gradient), inhibiting the filtration of macromolecular assemblies, such as the transgene construct.
Coronary sinus balloon position and occlusion of coronary sinus vein
Two principles that are fundamental to the MCARDீ procedure are internal occlusion of the coronary sinus by balloon inflation and the external temporal occlusion of any coronary veins that drain into the coronary sinus proximal to the balloon position with temporary snares. It has been determined that coronary sinus balloon occlusion during retrograde infusion improves cardioplegia delivery and also results in a doubling of nutrient flow w11x. When the retrograde catheter is mal-positioned, the loss of Downloaded from https://academic.oup.com/icvts/article-abstract/11/6/727/830137 by guest on 28 December 2018 regurgitated volume through the veno-venous anastomosis can range up to 36% w12x. To reduce the loss of input virus, and to avoid decompression of the coronary venous system, we temporarily use a snare to occlude the middle cardiac vein. We saw no complications resulting with this technique in any of the cases.
Coronary sinus pressure and flow
It has been previously demonstrated in several studies that an increased perfusion pressure in the coronary arteries enhances myocardial gene transfer w1x. Does this premise hold true for the coronary venous system? In general, the coronary sinus pressure is limited to 40-60 mmHg to prevent coronary sinus injury, peripheral vascular edema and hemorrhage. In the canine model, it was noted that damage to the capillaries and venules occurred when the perfusion pressure in the coronary sinus rose above 60 mmHg w13x. Conversely, a study of Eke et al. w14x showed that in the vented arrested heart, the coronary sinus pressure could safely be increased to up to 120 mmHg. In this study we have never observed histological evidence of myocardial edema or any other injury at the four-week time point for coronary sinus pressures -100 mmHg. During coronary sinus pressure elevation, venous flow more readily enters the capillary channels and is associated with a faster and more uniform distribution of nutrient flow w15x, possibly due to distending the veins thus rendering valves incompetent.
Limitations of the study
The present experiments were performed with a relatively small number of animals, and normal sheep were used, which were without evidence of coronary artery disease or heart failure. Although coronary venous and arterial anatomy of the sheep is similar to that of humans, this study cannot necessarily be extrapolated to patients. Coronary sinus pressure and flow used in these experiments were constant, in efforts to evaluate transduction efficiency under controlled conditions. MCARDீ is utilized as a title trademark to avoid confusion of this methodology with other competing platforms.
Conclusions
MCARDீ is a cardiac vector-mediated gene delivery platform that is 99.6% efficient in restricting vector genomes to the coronary circulation. This method uniquely allows for high-efficiency recirculating gene delivery to the coronary circulation of large animals while minimizing collateral organ expression and is potentially clinically translatable for heart failure gene therapy.
